Baker Bros. Advisors as of Sept. 30, 2016
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 134 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 21.6 | $2.4B | 44M | 54.01 | |
| Incyte Corporation (INCY) | 20.1 | $2.2B | 24M | 94.29 | |
| Abbvie (ABBV) | 8.2 | $905M | 14M | 63.07 | |
| ACADIA Pharmaceuticals (ACAD) | 7.5 | $821M | 26M | 31.81 | |
| Alexion Pharmaceuticals | 7.3 | $802M | 6.5M | 122.54 | |
| Incyte Corp Ltd conv | 4.8 | $533M | 275M | 1.94 | |
| Incyte Corp Incy Cvt 144a 0.37 convert | 4.5 | $492M | 259M | 1.90 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $445M | 4.8M | 92.52 | |
| Genomic Health | 3.6 | $398M | 14M | 28.92 | |
| Dbv Technologies S A (DBVT) | 1.8 | $200M | 5.5M | 36.33 | |
| Aquinox Pharmaceuticals | 1.3 | $141M | 11M | 13.36 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.9 | $101M | 22M | 4.53 | |
| Bellicum Pharma | 0.9 | $97M | 4.9M | 19.90 | |
| Cerus Corporation (CERS) | 0.7 | $81M | 13M | 6.21 | |
| Spark Therapeutics | 0.7 | $79M | 1.3M | 60.06 | |
| Acorda Therapeutics | 0.7 | $76M | 3.7M | 20.88 | |
| Clovis Oncology Inc note 2.500% 9/1 | 0.6 | $69M | 73M | 0.95 | |
| Amarin Corporation (AMRN) | 0.6 | $66M | 21M | 3.19 | |
| Exelixis (EXEL) | 0.6 | $63M | 4.9M | 12.79 | |
| Acorda Therap note 1.75% 6/15 | 0.6 | $63M | 77M | 0.82 | |
| Beigene (BGNE) | 0.5 | $59M | 1.9M | 30.81 | |
| Invitae (NVTAQ) | 0.5 | $57M | 6.6M | 8.76 | |
| Heron Therapeutics (HRTX) | 0.5 | $49M | 2.9M | 17.23 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $48M | 11M | 4.41 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $45M | 895k | 50.64 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.4 | $39M | 1.0M | 38.08 | |
| Versartis | 0.2 | $26M | 2.1M | 12.25 | |
| Progenics Pharmaceuticals | 0.2 | $23M | 3.7M | 6.33 | |
| Foamix Pharmaceuticals | 0.2 | $23M | 2.5M | 9.26 | |
| Array BioPharma | 0.2 | $22M | 3.3M | 6.75 | |
| Halozyme Therapeutics (HALO) | 0.2 | $21M | 1.7M | 12.08 | |
| Xencor (XNCR) | 0.2 | $21M | 872k | 24.49 | |
| Achillion Pharmaceuticals | 0.2 | $20M | 2.5M | 8.10 | |
| Bluebird Bio (BLUE) | 0.2 | $20M | 294k | 67.78 | |
| Merus N V (MRUS) | 0.2 | $19M | 1.2M | 16.75 | |
| Sangamo Biosciences (SGMO) | 0.2 | $19M | 4.1M | 4.63 | |
| Idera Pharmaceuticals | 0.2 | $18M | 7.0M | 2.56 | |
| Derma Sciences | 0.2 | $18M | 3.8M | 4.67 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.2 | $18M | 27M | 0.66 | |
| Intellia Therapeutics (NTLA) | 0.2 | $18M | 1.1M | 17.02 | |
| Galapagos Nv- (GLPG) | 0.1 | $17M | 260k | 64.66 | |
| Tg Therapeutics (TGTX) | 0.1 | $16M | 2.0M | 7.74 | |
| Mirati Therapeutics | 0.1 | $15M | 2.3M | 6.61 | |
| Ascendis Pharma A S (ASND) | 0.1 | $15M | 746k | 20.10 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $15M | 12M | 1.20 | |
| Vitae Pharmaceuticals | 0.1 | $13M | 638k | 20.92 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $14M | 1.9M | 7.35 | |
| Alkermes (ALKS) | 0.1 | $12M | 250k | 47.03 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $11M | 208k | 52.82 | |
| Macrogenics (MGNX) | 0.1 | $11M | 364k | 29.91 | |
| Aerie Pharmaceuticals | 0.1 | $11M | 299k | 37.74 | |
| Dermira | 0.1 | $11M | 326k | 33.82 | |
| Zogenix | 0.1 | $11M | 1.0M | 11.43 | |
| Sage Therapeutics (SAGE) | 0.1 | $9.6M | 208k | 46.05 | |
| Contrafect | 0.1 | $10M | 4.0M | 2.48 | |
| Aimmune Therapeutics | 0.1 | $10M | 674k | 15.00 | |
| Dimension Therapeutics | 0.1 | $10M | 1.3M | 7.99 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $9.3M | 609k | 15.24 | |
| ImmunoGen | 0.1 | $8.1M | 3.0M | 2.68 | |
| Ligand Pharmaceuticals In (LGND) | 0.1 | $7.5M | 73k | 102.06 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $7.1M | 100k | 70.94 | |
| Alder Biopharmaceuticals | 0.1 | $7.1M | 217k | 32.77 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $6.1M | 414k | 14.79 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $6.7M | 5.0M | 1.34 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $5.6M | 5.1M | 1.09 | |
| Insmed (INSM) | 0.1 | $5.8M | 400k | 14.52 | |
| Alcobra | 0.1 | $5.8M | 2.3M | 2.47 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $5.7M | 861k | 6.67 | |
| Neuroderm Ltd F | 0.1 | $5.6M | 305k | 18.49 | |
| Natera (NTRA) | 0.1 | $5.0M | 450k | 11.11 | |
| Medgenics | 0.0 | $4.9M | 881k | 5.57 | |
| Akari Therapeutics | 0.0 | $4.2M | 497k | 8.51 | |
| D Stemline Therapeutics | 0.0 | $3.6M | 334k | 10.83 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.0 | $3.6M | 3.0M | 1.19 | |
| Trevena | 0.0 | $3.0M | 450k | 6.75 | |
| Concert Pharmaceuticals I equity | 0.0 | $3.2M | 317k | 10.11 | |
| Ignyta | 0.0 | $3.6M | 571k | 6.29 | |
| Adamas Pharmaceuticals | 0.0 | $2.8M | 173k | 16.41 | |
| Loxo Oncology | 0.0 | $3.6M | 138k | 26.18 | |
| Minerva Neurosciences | 0.0 | $3.7M | 259k | 14.11 | |
| Proteon Therapeutics | 0.0 | $2.8M | 299k | 9.33 | |
| Syros Pharmaceuticals | 0.0 | $2.8M | 205k | 13.87 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $3.2M | 742k | 4.37 | |
| Osiris Therapeutics | 0.0 | $2.5M | 499k | 4.96 | |
| Endocyte | 0.0 | $2.7M | 869k | 3.09 | |
| Enanta Pharmaceuticals (ENTA) | 0.0 | $2.0M | 75k | 26.61 | |
| Epizyme | 0.0 | $2.3M | 233k | 9.84 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $2.1M | 217k | 9.73 | |
| Glycomimetics (GLYC) | 0.0 | $2.7M | 381k | 7.15 | |
| Uniqure Nv (QURE) | 0.0 | $1.8M | 230k | 7.65 | |
| Mediwound Ltd cmn | 0.0 | $1.7M | 226k | 7.70 | |
| Scynexis | 0.0 | $1.8M | 468k | 3.87 | |
| Assembly Biosciences | 0.0 | $1.8M | 250k | 7.21 | |
| Juno Therapeutics | 0.0 | $2.4M | 80k | 30.01 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.3M | 3.4M | 0.67 | |
| Invivo Therapeutics Hldgs | 0.0 | $2.7M | 400k | 6.80 | |
| Nabriva Therapeutics | 0.0 | $2.5M | 350k | 7.05 | |
| Ionis Pharmaceuticals (IONS) | 0.0 | $2.1M | 57k | 36.65 | |
| Selecta Biosciences (RNAC) | 0.0 | $2.6M | 179k | 14.25 | |
| Aeglea Biotherapeutics | 0.0 | $2.6M | 404k | 6.41 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $905k | 580k | 1.56 | |
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $769k | 11k | 67.81 | |
| BioDelivery Sciences International | 0.0 | $567k | 210k | 2.70 | |
| Palatin Technologies | 0.0 | $1.3M | 2.1M | 0.63 | |
| Mast Therapeutics | 0.0 | $944k | 8.6M | 0.11 | |
| Chimerix (CMRX) | 0.0 | $638k | 115k | 5.54 | |
| Acceleron Pharma | 0.0 | $1.0M | 29k | 36.19 | |
| Ophthotech | 0.0 | $1.6M | 36k | 46.12 | |
| Five Prime Therapeutics | 0.0 | $1.0M | 19k | 52.48 | |
| Aldeyra Therapeutics (ALDX) | 0.0 | $1.1M | 142k | 7.82 | |
| Immune Design | 0.0 | $1.1M | 149k | 7.58 | |
| Tenax Therapeutics | 0.0 | $970k | 420k | 2.31 | |
| Affimed Therapeutics B V | 0.0 | $1.1M | 400k | 2.78 | |
| Dynavax Technologies (DVAX) | 0.0 | $787k | 75k | 10.49 | |
| Aptose Biosciences | 0.0 | $910k | 404k | 2.25 | |
| Cellectis S A (CLLS) | 0.0 | $1.2M | 50k | 24.08 | |
| Abeona Therapeutics | 0.0 | $610k | 102k | 6.00 | |
| Seres Therapeutics (MCRB) | 0.0 | $1.5M | 125k | 12.29 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $705k | 100k | 7.05 | |
| Colucid Pharmaceuticals | 0.0 | $1.2M | 30k | 38.14 | |
| Arbutus Biopharma (ABUS) | 0.0 | $621k | 181k | 3.44 | |
| Ritter Pharmaceuticals | 0.0 | $672k | 400k | 1.68 | |
| Myokardia | 0.0 | $1.6M | 100k | 16.34 | |
| Windtree Therapeutics | 0.0 | $653k | 255k | 2.56 | |
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $732k | 58k | 12.67 | |
| Fulgent Genetics (FLGT) | 0.0 | $1.2M | 125k | 9.22 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $90k | 13k | 6.79 | |
| Chemocentryx | 0.0 | $296k | 49k | 6.03 | |
| Cytrx | 0.0 | $389k | 660k | 0.59 | |
| Foundation Medicine | 0.0 | $488k | 21k | 23.36 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $327k | 14k | 23.79 | |
| Achaogen | 0.0 | $479k | 100k | 4.79 | |
| Biotime Inc wts oct 1 18 | 0.0 | $17k | 20k | 0.85 | |
| Pronai Therapeutics | 0.0 | $364k | 200k | 1.82 |
